Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice

Article

Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
David Brousseau, MD, highlights impact of timely opioid dosing in pediatric sickle cell pain
Richard Bermudes, MD, on screen-related addictions and youth mental health
© 2025 MJH Life Sciences

All rights reserved.